Gluckman E
Bone Marrow Transplant Unit, Hospital Saint-Louis, Paris, France.
Radiother Oncol. 1990;18 Suppl 1:88-93. doi: 10.1016/0167-8140(90)90182-v.
Fanconi anemia is characterised by pancytopenia, malformations and chromosomal breaks probably related to a congenital defect of DNA repair mechanisms. The evolution is always fatal unless, the patient receives a bone marrow transplant from an HLA identical sibling. According to preliminary work on sensitivity of FA cells to alkylating agents and to in vivo radiosensitivity tests, we used a modified conditioning regimen with cyclophosphamide 20 mg/kg and 5 Grays thoraco-abdominal irradiation. Nineteen patients are reported. The actuarial survival is 74% with a median follow-up time of 4 years (range 6 months to 6 years). GVH was the main complication (58%). It was responsible directly or indirectly for 4 deaths. These results show that BMT in FA is successful in the large majority of cases. The decrease of the dose cyclophosphamide allowed a good engraftment without major toxicity. Studies are in progress for using this type of protocol in situations without a HLA matched sibling donor.
范可尼贫血的特征是全血细胞减少、畸形以及可能与先天性DNA修复机制缺陷相关的染色体断裂。除非患者接受来自人类白细胞抗原(HLA)匹配同胞的骨髓移植,否则病情发展往往是致命的。根据关于范可尼贫血(FA)细胞对烷化剂的敏感性以及体内放射敏感性测试的初步研究,我们采用了一种改良的预处理方案,即使用20毫克/千克的环磷酰胺和5格雷的胸腹部照射。本文报告了19例患者。精算生存率为74%,中位随访时间为4年(范围为6个月至6年)。移植物抗宿主病(GVH)是主要并发症(58%)。它直接或间接导致了4例死亡。这些结果表明,大多数情况下,范可尼贫血患者进行骨髓移植是成功的。环磷酰胺剂量的降低使得植入良好且无重大毒性。目前正在进行研究,以便在没有HLA匹配同胞供体的情况下使用这种方案。